# Vir Biotechnology, Inc.: filings

VIR · Nasdaq · CIK 1706431 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vir.md) · [Financials](/companies/vir/financials.md) · [Filings](/companies/vir/filings.md) · [Insiders](/companies/vir/insiders.md)

## Reports and events: 152 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 433, 8-K 106, 144 71, 3 38, 10-Q 21, SC 13G/A 12, 4/A 11, DEFA14A 9, S-8 8, SC 13G 8, 10-K 7, CORRESP 7, DEF 14A 7, SC 13D/A 6, ARS 4, SCHEDULE 13G/A 4, UPLOAD 4, 5 3, D 3, 424B4 2, 424B5 2, DRS 2, EFFECT 2, S-1 2, S-3ASR 2, SEC STAFF LETTER 2, 3/A 1, 8-A12B 1, CERT 1, DRS/A 1, DRSLTR 1, POS EX 1, S-1/A 1, S-1MEF 1, SC 13D 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 08:37 ET | [8-K](/filings/0001628280-26-067742.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-067742 |
| 2026-10-14 | 08:35 ET | [8-K](/filings/0001628280-26-065826.md) | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-065826 |
| 2026-10-08 | 08:38 ET | [8-K](/filings/0001628280-26-065408.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-065408 |
| 2026-10-01 | 08:34 ET | [8-K](/filings/0001628280-26-064117.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-064117 |
| 2026-08-05 | 17:20 ET | [10-Q](/filings/0001628280-26-053549.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053549 |
| 2026-08-05 | 16:09 ET | [8-K](/filings/0001628280-26-053351.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053351 |
| 2026-07-24 | 08:31 ET | [8-K](/filings/0001628280-26-049499.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-049499 |
| 2026-06-10 | 16:27 ET | [8-K](/filings/0001628280-26-042237.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-042237 |
| 2026-05-28 | 09:01 ET | [8-K](/filings/0001628280-26-038630.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001628280-26-038630 |
| 2026-05-07 | 17:32 ET | [10-Q](/filings/0001628280-26-031471.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031471 |
| 2026-05-06 | 16:11 ET | [8-K](/filings/0001628280-26-031273.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031273 |
| 2026-04-16 | 08:46 ET | [DEF 14A](/filings/0001628280-26-025379.md) | Proxy statement, period 2025-12-31 | 0001628280-26-025379 |
| 2026-04-10 | 16:01 ET | [8-K](/filings/0001193125-26-151209.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-151209 |
| 2026-03-04 | 16:01 ET | [8-K](/filings/0001193125-26-091447.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-091447 |
| 2026-03-03 | 17:00 ET | [SCHEDULE 13D/A](/filings/0001012975-26-000222.md) | Ownership report, active investor, amended | 0001012975-26-000222 |
| 2026-03-02 | 09:01 ET | [8-K](/filings/0001193125-26-084367.md) | 8.01 Other events | 0001193125-26-084367 |
| 2026-02-26 | 17:20 ET | [8-K](/filings/0001193125-26-077416.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-077416 |
| 2026-02-23 | 17:27 ET | [10-K](/filings/0001628280-26-010749.md) | Annual report, period 2025-12-31 | 0001628280-26-010749 |
| 2026-02-23 | 17:16 ET | [8-K](/filings/0001628280-26-010740.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-010740 |
| 2026-01-12 | 08:07 ET | [8-K](/filings/0001628280-26-001768.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001768 |
| 2025-12-16 | 16:25 ET | [8-K](/filings/0001628280-25-057394.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-057394 |
| 2025-11-05 | 17:15 ET | [10-Q](/filings/0001628280-25-049694.md) | Quarterly report, period 2025-09-30 | 0001628280-25-049694 |
| 2025-11-05 | 16:12 ET | [8-K](/filings/0001628280-25-049561.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049561 |
| 2025-08-06 | 17:31 ET | [10-Q](/filings/0001628280-25-038431.md) | Quarterly report, period 2025-06-30 | 0001628280-25-038431 |
| 2025-08-06 | 16:09 ET | [8-K](/filings/0001628280-25-038329.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038329 |
| 2025-07-24 | 09:05 ET | [8-K](/filings/0001628280-25-035847.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-035847 |
| 2025-05-29 | 16:21 ET | [8-K](/filings/0001628280-25-028356.md) | 5.07 Shareholder vote results | 0001628280-25-028356 |
| 2025-05-09 | 08:23 ET | [8-K](/filings/0001628280-25-024067.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-024067 |
| 2025-05-08 | 17:33 ET | [10-Q](/filings/0001628280-25-023291.md) | Quarterly report, period 2025-03-31 | 0001628280-25-023291 |
| 2025-05-07 | 16:13 ET | [8-K](/filings/0001628280-25-023175.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-023175 |
| 2025-04-17 | 08:33 ET | [DEF 14A](/filings/0001628280-25-018119.md) | Proxy statement, period 2025-05-29 | 0001628280-25-018119 |
| 2025-02-27 | 17:34 ET | [10-K](/filings/0001628280-25-008245.md) | Annual report, period 2024-12-31 | 0001628280-25-008245 |
| 2025-02-26 | 16:17 ET | [8-K](/filings/0001628280-25-008163.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-008163 |
| 2025-01-30 | 07:51 ET | [8-K](/filings/0001628280-25-003073.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-003073 |
| 2025-01-08 | 07:50 ET | [8-K](/filings/0001193125-25-003214.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-003214 |
| 2024-11-04 | 16:09 ET | [10-Q](/filings/0001628280-24-044995.md) | Quarterly report, period 2024-09-30 | 0001628280-24-044995 |
| 2024-10-31 | 16:20 ET | [8-K](/filings/0001628280-24-044563.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-044563 |
| 2024-09-10 | 08:10 ET | [8-K](/filings/0001628280-24-039948.md) | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-039948 |
| 2024-08-01 | 16:43 ET | [10-Q](/filings/0001628280-24-034195.md) | Quarterly report, period 2024-06-30 | 0001628280-24-034195 |
| 2024-08-01 | 16:10 ET | [8-K](/filings/0001628280-24-034143.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001628280-24-034143 |
| 2024-08-01 | 16:08 ET | [8-K](/filings/0001193125-24-191500.md) | 1.01 Entry into a material agreement | 0001193125-24-191500 |
| 2024-06-26 | 08:15 ET | [8-K](/filings/0001193125-24-168554.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-168554 |
| 2024-06-05 | 06:04 ET | [8-K](/filings/0001193125-24-154636.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-154636 |
| 2024-05-29 | 16:06 ET | [8-K](/filings/0001193125-24-149139.md) | 5.07 Shareholder vote results | 0001193125-24-149139 |
| 2024-05-03 | 16:16 ET | [10-Q](/filings/0001628280-24-020299.md) | Quarterly report, period 2024-03-31 | 0001628280-24-020299 |
| 2024-05-02 | 16:09 ET | [8-K](/filings/0001628280-24-020009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-020009 |
| 2024-04-19 | 08:32 ET | [DEF 14A](/filings/0001140361-24-020684.md) | Proxy statement, period 2024-05-29 | 0001140361-24-020684 |
| 2024-04-18 | 08:44 ET | [8-K](/filings/0001193125-24-100072.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-100072 |
| 2024-02-26 | 16:10 ET | [10-K](/filings/0001628280-24-006852.md) | Annual report, period 2023-12-31 | 0001628280-24-006852 |
| 2024-02-22 | 16:12 ET | [8-K](/filings/0001628280-24-006346.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-006346 |

Page 1 of 4. [Older](/companies/vir/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 08:38 ET. No prices; not investment advice.